Tina Moore
π€ SpeakerAppearances Over Time
Podcast Appearances
Well, and we have to take into consideration risk tolerance, right? This is something that comes up. I saw this so often during COVID was people suddenly out of nowhere demanding your source, right? Which I'm all for, but I would never say something. I'm a physician with a license and I take it very seriously that I have hundreds of thousands of people listening to me.
Well, and we have to take into consideration risk tolerance, right? This is something that comes up. I saw this so often during COVID was people suddenly out of nowhere demanding your source, right? Which I'm all for, but I would never say something. I'm a physician with a license and I take it very seriously that I have hundreds of thousands of people listening to me.
Well, and we have to take into consideration risk tolerance, right? This is something that comes up. I saw this so often during COVID was people suddenly out of nowhere demanding your source, right? Which I'm all for, but I would never say something. I'm a physician with a license and I take it very seriously that I have hundreds of thousands of people listening to me.
And I would never just say something random, right? because I heard it somewhere else. Like I always check my source, but you can't always provide all your sources because a lot of this is knowledge that you've acquired. I mean, because I understand how something works, I don't need a source for everything to explain physiology, right? Or to explain pathophysiology, for example.
And I would never just say something random, right? because I heard it somewhere else. Like I always check my source, but you can't always provide all your sources because a lot of this is knowledge that you've acquired. I mean, because I understand how something works, I don't need a source for everything to explain physiology, right? Or to explain pathophysiology, for example.
And I would never just say something random, right? because I heard it somewhere else. Like I always check my source, but you can't always provide all your sources because a lot of this is knowledge that you've acquired. I mean, because I understand how something works, I don't need a source for everything to explain physiology, right? Or to explain pathophysiology, for example.
And I think that... When I talk to patients about peptides, I was in the regenerative medicine space for a long time. And so everything we were using was pretty novel. And I would explain to patients the pros and cons, but ultimately it came down to risk tolerance. And my argument on that is, are we going... A couple of things.
And I think that... When I talk to patients about peptides, I was in the regenerative medicine space for a long time. And so everything we were using was pretty novel. And I would explain to patients the pros and cons, but ultimately it came down to risk tolerance. And my argument on that is, are we going... A couple of things.
And I think that... When I talk to patients about peptides, I was in the regenerative medicine space for a long time. And so everything we were using was pretty novel. And I would explain to patients the pros and cons, but ultimately it came down to risk tolerance. And my argument on that is, are we going... A couple of things.
Are we going to harm you by implementing this strategy or utilizing these supplements or whatnot? If the benefit far outweighs the risk, and I would share both, then it was up to them what they wanted to do. And ultimately, when we look at evidence-based medicine, everybody wants to hang on study, study, study, studies. But evidence-based medicine is a three-legged stool.
Are we going to harm you by implementing this strategy or utilizing these supplements or whatnot? If the benefit far outweighs the risk, and I would share both, then it was up to them what they wanted to do. And ultimately, when we look at evidence-based medicine, everybody wants to hang on study, study, study, studies. But evidence-based medicine is a three-legged stool.
Are we going to harm you by implementing this strategy or utilizing these supplements or whatnot? If the benefit far outweighs the risk, and I would share both, then it was up to them what they wanted to do. And ultimately, when we look at evidence-based medicine, everybody wants to hang on study, study, study, studies. But evidence-based medicine is a three-legged stool.
And one leg of that stool is studies and data. And the other two legs, one of them being the patient's experience and needs and wants, And one of them being the clinician's experience and expertise, right? That's the triad of evidence-based medicine. And so sometimes we extrapolate from animal studies, yeah.
And one leg of that stool is studies and data. And the other two legs, one of them being the patient's experience and needs and wants, And one of them being the clinician's experience and expertise, right? That's the triad of evidence-based medicine. And so sometimes we extrapolate from animal studies, yeah.
And one leg of that stool is studies and data. And the other two legs, one of them being the patient's experience and needs and wants, And one of them being the clinician's experience and expertise, right? That's the triad of evidence-based medicine. And so sometimes we extrapolate from animal studies, yeah.
But it's not that we're... For the folks that don't... Like a lot of folks don't get how science works. It's not just that, okay, it worked in mice, so I think it's going to work in humans. No. If the study or the data that we have explains the mechanism of action in a mammalian species... and the pathways that I can better understand how that might work in a human, right?
But it's not that we're... For the folks that don't... Like a lot of folks don't get how science works. It's not just that, okay, it worked in mice, so I think it's going to work in humans. No. If the study or the data that we have explains the mechanism of action in a mammalian species... and the pathways that I can better understand how that might work in a human, right?
But it's not that we're... For the folks that don't... Like a lot of folks don't get how science works. It's not just that, okay, it worked in mice, so I think it's going to work in humans. No. If the study or the data that we have explains the mechanism of action in a mammalian species... and the pathways that I can better understand how that might work in a human, right?
And so that's where I think things get hung up. GLP-1 is an example with the black box warning and the rat studies, right? The black box warning was on rats. The interesting part about that is rats and rodents have a receptor for GLP-1 on their thyroid that humans don't have the same receptor, which could potentially lead them down the path to this medullary thyroid cancer risk.
And so that's where I think things get hung up. GLP-1 is an example with the black box warning and the rat studies, right? The black box warning was on rats. The interesting part about that is rats and rodents have a receptor for GLP-1 on their thyroid that humans don't have the same receptor, which could potentially lead them down the path to this medullary thyroid cancer risk.